PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 208 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $14,000 | +7.7% | 428 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $13,000 | -35.0% | 428 | 0.0% | 0.01% | -36.4% |
| Q4 2017 | $20,000 | +25.0% | 428 | 0.0% | 0.01% | +10.0% |
| Q3 2017 | $16,000 | -20.0% | 428 | 0.0% | 0.01% | -23.1% |
| Q2 2017 | $20,000 | 0.0% | 428 | 0.0% | 0.01% | +8.3% |
| Q1 2017 | $20,000 | +42.9% | 428 | 0.0% | 0.01% | +33.3% |
| Q4 2016 | $14,000 | -6.7% | 428 | 0.0% | 0.01% | -10.0% |
| Q3 2016 | $15,000 | +7.1% | 428 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $14,000 | -39.1% | 428 | 0.0% | 0.01% | -44.4% |
| Q1 2016 | $23,000 | -32.4% | 428 | -2.9% | 0.02% | -30.8% |
| Q4 2015 | $34,000 | +466.7% | 441 | +194.0% | 0.03% | +420.0% |
| Q3 2015 | $6,000 | -45.5% | 150 | 0.0% | 0.01% | -37.5% |
| Q2 2015 | $11,000 | -15.4% | 150 | 0.0% | 0.01% | -11.1% |
| Q1 2015 | $13,000 | 0.0% | 150 | 0.0% | 0.01% | -10.0% |
| Q4 2014 | $13,000 | -13.3% | 150 | 0.0% | 0.01% | -23.1% |
| Q3 2014 | $15,000 | +7.1% | 150 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $14,000 | +40.0% | 150 | 0.0% | 0.01% | +18.2% |
| Q1 2014 | $10,000 | +11.1% | 150 | 0.0% | 0.01% | +120.0% |
| Q4 2013 | $9,000 | -25.0% | 150 | -40.0% | 0.01% | -28.6% |
| Q3 2013 | $12,000 | +71.4% | 250 | 0.0% | 0.01% | +40.0% |
| Q2 2013 | $7,000 | – | 250 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,799,916 | $121,768,000 | 8.62% |
| Tamarack Advisers, LP | 625,000 | $27,044,000 | 8.22% |
| NEXTHERA CAPITAL LP | 149,086 | $6,484,000 | 5.40% |
| Spyglass Capital Management LLC | 379,609 | $16,509,000 | 5.22% |
| Gagnon Advisors, LLC | 107,412 | $4,671,000 | 2.67% |
| GAGNON SECURITIES LLC | 278,613 | $12,117,000 | 2.61% |
| Asymmetry Capital Management, L.P. | 84,735 | $3,685,000 | 2.00% |
| Rock Springs Capital Management LP | 1,250,000 | $54,363,000 | 1.97% |
| Lisanti Capital Growth, LLC | 118,620 | $5,159,000 | 1.68% |
| Elk Creek Partners, LLC | 500,069 | $21,748,000 | 1.62% |